Biopharmas (mostly) meet mandatory trial reporting but fall flat voluntarily
20 November 2015
The decade-old drumbeat for clinical trials transparency grew louder with release of a paper in BMJ Open about the dearth of voluntary data reporting – sometimes even from late-stage trials – on drugs that were subsequently approved.
Broken Market for Old Drugs Means Price Spikes Are Here to Stay
20 November 2015
With most products, you’d expect a flood of new supply to quickly drive back down a price spike caused by a temporary shortage. Not so in the topsy-turvy world of hospital pharmaceuticals.
Cancer Cell-Therapy Companies Scale Up in Race to Lower Costs
19 November 2015
For companies racing to develop cell therapies for cancer, building up production capacity while bringing down the cost of new drugmaking processes is a top priority alongside clinical testing.
NIH-led effort details global brain disorders research agenda in Nature supplement
19 November 2015
Infants are starved of oxygen during difficult births. Children’s cognitive function is permanently damaged due to malnutrition or exposure to infections or toxins. Adults suffer from crippling depression or dementia. The breadth and complexity of these and other brain and nervous system disorders make them some of the most difficult conditions to diagnose and treat, especially in the developing world, where there are few resources.
19 November 2015
More than half of the world’s population will live in countries where medicine use will exceed one dose per person per day by 2020, up from 31 percent in 2005, as the “medicine use gap” between developed and pharmerging markets narrows. According to new research released today by the IMS Institute for Healthcare Informatics, total spending on medicines will reach $1.4 trillion by 2020 due to greater patient access to chronic disease treatments and breakthrough innovations in drug therapies. Global spending is forecast to grow at a 4-7 percent compound annual rate over the next five years.
FDA calls for beefed-up oversight of lab-developed tests
19 November 2015
The FDA is calling for more oversight of lab-developed tests (LDTs) in the wake of a congressional hearing about the agency's ability to regulate the products, pointing to a new internal report that says certain LDTs "may have caused or have caused" harm to patients by producing incorrect results.
New Diagnostic Tools Emerge in War Against Superbugs
19 November 2015
A new front is emerging in the fight against antibiotic-resistant superbugs—one that doesn’t involve the development of new drugs. Companies are racing to develop diagnostic technologies that can be used by hospitals and clinics to pinpoint the cause of common infections quickly. That should cut down on the unnecessary prescription of antibiotics, a major driver of drug-resistance in bacteria.
Blacklisting Icahn: How Some Drug Companies Keep Out Activists
18 November 2015
When Concordia Healthcare Corp. agreed to issue a 14 percent stake to a private equity firm, the Canadian drug manufacturer tucked into the deal several layers of protection from shareholder activists.
Indian drugmakers eye Japanese market for acquisitions
18 November 2015
Indian drug companies are said to be trying to widen their presence in Japan, the world's second-largest pharmaceutical market, according to a report by Livemint.
Forbes: For multinationals, CFDA reform paramount
18 November 2015
Forbes magazine recently polled 50 drug multinational company executives asking them what was most important in their dealings with China, and 86% of those interviewed said reforms to the China Food and Drug Administration (CFDA) "were going to be essential for their company's future" there.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russia has expanded the mandatory health insurance program for 2024-2026
29 March 2024
Russian scientists have developed new TB vaccines for both injection and nasal administration.
29 March 2024
The overall mortality rate of the population in Russia decreased by 7% in 2023
28 March 2024
Russia to collaborate with Hungary and Serbia in nuclear medicine
28 March 2024